Clinical Trial Protocol Deviations: Classification, Documentation, and Reporting

Major vs. minor deviation definitions with classification examples, immediate 7-step response procedure, IRB and sponsor reporting timelines by deviation type, deviation log required fields, source document amendment standards, monthly trending metrics, and a 16-item deviation management checklist.

Clinical Trial CAPA and Quality Management: Root Cause Analysis and Preventive Action

CAPA triggers (deviations, audit findings, Form 483 observations), 5 Whys methodology with worked example, corrective vs preventive action distinctions, 8-element CAPA documentation structure, effectiveness checks by action type, quality trending metrics, and a 16-item CAPA checklist.

Clinical Trial Inspection Readiness: Preparing for FDA BIMO and Sponsor Audits

BIMO inspection types and triggers, preparation timeline from notice to day-before, ISF document readiness requirements, the 7 most common Form 483 findings, staff interview coaching principles, close-out meeting conduct, and a 16-item inspection readiness checklist.

Clinical Trial Data Lock: Query Resolution, Database Freeze, and Post-Lock Procedures

Pre-lock query resolution priorities (critical/major/minor), SAE and IVRS reconciliation, the data lock meeting agenda, database freeze procedure, unblinding sequence for analysis, post-lock amendment process, and a 16-item data lock checklist.

Clinical Trial Site Activation: From Contract to First Patient Enrolled

The full activation sequence — site qualification visit, contract and budget negotiation (screen failure rates, overhead, amendment pricing), IRB submission package, Form 1572 and financial disclosures, site initiation visit agenda, and a 16-item activation checklist.

Clinical Trial Randomization and Blinding: IVRS, Stratification, and Unblinding Procedures

Randomization scheme types (permuted block, stratified, minimization), stratification factor capture, IVRS/IWRS operations, blinding integrity procedures, emergency unblinding criteria and documentation, and a 16-item compliance checklist.

Clinical Trial Safety Reporting: SAEs, SUSARs, and Expedited Reporting

SAE definitions and the six seriousness criteria, 7-day and 15-day reporting timelines, SUSAR identification (serious + unexpected + related), MedWatch and CIOMS forms, site vs. sponsor responsibilities, IRB notification obligations, follow-up narrative structure, and a 16-item safety checklist.

Clinical Trial Laboratory Requirements: Central vs. Local Labs, Normal Ranges, and Sample Management

CLIA/CAP regulatory framework, central vs. local lab trade-offs, normal range filing and eCRF matching, specimen collection pre-analytical variables, chain of custody, managing local lab relationships, and a 16-item lab compliance checklist.

Clinical Trial Visit Windows: Managing Scheduling, Missed Visits, and Protocol Deviations

Calculating visit windows from reference dates, visit priority tiers (critical/major/minor), proactive scheduling reminder cadence, rescue procedures when visits are at risk, deviation documentation and CAPA requirements, and the 14-item visit window compliance checklist.

Trial Master File (TMF): Essential Documents, Organization, and Inspection Readiness

ICH E6(R2) essential document requirements by phase (pre-trial, conduct, close-out), site ISF vs. sponsor TMF, eTMF systems, FDA BIMO inspection focus areas, delegation of authority log, common 483 observations, and the 20-item TMF completeness checklist.

Subject Withdrawal and Early Termination in Clinical Trials

Voluntary withdrawal, investigator-initiated discontinuation, lost to follow-up (3-attempt standard), protocol-mandated stopping, IP reconciliation at withdrawal, safety follow-up obligations after discontinuation, and the 18-item subject withdrawal checklist.

Clinical Trial Source Documents: Requirements, Retention, and Audit Trail

What counts as source data, ALCOA-C principles, electronic source and 21 CFR Part 11 audit trail requirements, Source Data Agreements, certified copies, document retention timelines, and the 16-item source document readiness checklist.

Clinical Trial Monitoring Visits: What Sites Need to Know

All five visit types (SQV, SIV, IMV, COV, for-cause), SIV checklist, IMV 6-step agenda, SDV vs. SDR comparison, findings severity classification (Critical/Major/Minor) with response timelines, risk-based monitoring, and the 14-item monitoring readiness checklist.

Good Clinical Practice (GCP) Training: Requirements, Frequency, and Compliance

ICH E6(R2) training obligations, who needs GCP training, CITI vs. TransCelerate, refresher frequency (2–3 year standard), documentation requirements, study-specific training logs, amendment training, and the 13-item training readiness checklist.

Investigational Product Management: Storage, Accountability, and Chain of Custody

IP receipt and verification, storage requirements by condition, continuous temperature monitoring, dispensing accountability equation, temperature excursion response, return and destruction, blinded study handling, and a 14-item pre-inspection readiness checklist.

Informed Consent in Clinical Trials: Process, Documentation, and Compliance

21 CFR Part 50 required elements, 8-step consent process, re-consent triggers, short-form consent for non-English speakers, consent for minors and cognitively impaired adults, documentation requirements, and the 7 most common FDA inspection deficiencies.

IRB Submissions and Continuing Review: A Site Coordinator's Complete Guide

21 CFR Part 56 and 45 CFR 46 review categories (exempt/expedited/full board), initial submission components, continuing review timelines, amendment triggers, reportable events, sIRB reliance, approval lapse consequences, and inspection readiness checklist.

Clinical Trial Data Management: ALCOA Principles and Source Documentation

ALCOA+ data quality principles (Attributable, Legible, Contemporaneous, Original, Accurate + Complete, Consistent, Enduring, Available), source data vs. EDC, corrections, audit trails, query management, and DCFs.

Clinical Trial Site Closeout: A Step-by-Step Guide for Research Coordinators

Closeout visit preparation, IP reconciliation, data query resolution, subject transition, document archiving requirements (15–25 years), IRB notifications, and the most common closeout findings.

Adverse Event Reporting in Clinical Trials: A Site Coordinator's Guide

AE vs. SAE definitions, the seven SAE criteria, 7-day and 15-day IND safety reporting timelines, site vs. sponsor obligations, SUSAR reporting, and the most common AE reporting errors.

Protocol Deviations and Amendments in Clinical Trials: A Site Operations Guide

Major vs. minor deviation classification, IRB and sponsor reporting timelines, CAPA documentation, amendment implementation steps, the most common deviations, and inspection readiness checklist.

Clinical Trial Regulatory Binder: What Goes In It and How to Keep It Audit-Ready

Required essential documents per ICH E6 R2, site file vs. sponsor TMF, how to organize tabs, electronic binders, the most commonly missing documents, and retention requirements.

Investigational Product Accountability in Clinical Trials: A Site Coordinator's Guide

Drug accountability logs, dispensing documentation, temperature monitoring, handling returns and expired product, close-out reconciliation, and the IP accountability gaps most frequently cited in FDA inspections.

Clinical Trial Patient Recruitment: Strategies That Actually Work for Research Sites

EHR pre-screening, physician referral networks, community partnerships, digital outreach, operational drop-off reduction, and the metrics that tell you whether your recruitment is working.

Informed Consent in Clinical Trials: Process, Documentation, and Common Pitfalls

Required ICF elements, re-consent triggers, documentation standards, vulnerable population protections, electronic consent, and the consent issues that most frequently appear in FDA inspection findings.

EDC Systems in Clinical Trials: A Site Coordinator's Guide to Electronic Data Capture

How EDC platforms work, data entry best practices that reduce query rates, audit trail requirements, query resolution workflows, and what FDA investigators look for in electronic records.

Clinical Trial Monitoring Visits: What Sites Need to Know

Types of monitoring visits (QV, SIV, RMV, COV, for-cause), what CRAs check during routine visits, how to prepare your site, closing findings, and building a productive monitor relationship.

Clinical Trial Staff Training Requirements: GCP, Protocol-Specific, and Delegation Log Essentials

ICH E6 R2 GCP training requirements, protocol-specific training obligations, delegation log documentation, mid-study onboarding procedures, and the training gaps that most commonly trigger FDA inspection findings.

Clinical Trial Site Feasibility: How to Evaluate and Win Studies That Fit Your Site

How sponsors evaluate sites, what makes a strong feasibility questionnaire response, patient pool estimation methodology, and the underrated skill of knowing when to decline.

Clinical Trial Budget Negotiation: What Sites Need to Know

Fair market value, coverage analysis, the line items most often left on the table, and the negotiation tactics that help research sites get budgets reflecting their actual costs.

Protocol Deviations in Clinical Trials: How Sites Document, Report, and Prevent Them

Major vs. minor classifications, IRB and sponsor reporting timelines, root cause analysis, CAPA requirements, and the site workflow that keeps deviations from becoming FDA inspection findings.

Adverse Event Reporting in Clinical Trials: A Site Guide to SAE Documentation and Timelines

SAE vs. AE vs. SUSAR, the 7-day and 15-day reporting rules, causality assessment, MedWatch vs. CIOMS, and the documentation errors that consistently trigger FDA findings at sites.

Diversity in Clinical Trial Recruitment: How Sites Can Meet FDA Diversity Action Plan Requirements

FDA now requires diversity action plans for many Phase 3 trials. What sites need to know about enrollment targets, outreach strategies, community partnerships, and reporting requirements.

eConsent in Clinical Trials: A Site Coordinator's Guide to Electronic Informed Consent

eConsent is replacing paper consent — but implementation is uneven. What site coordinators need to know about platforms, Part 11 compliance, comprehension workflows, and the four most common failure points.

Decentralized Clinical Trials: How Sites Can Run DCTs Without Losing Patients

DCTs reduce travel burden but introduce new dropout risks — tech fatigue, missed check-ins, and async communication gaps. How high-performing sites run decentralized trials without losing participants.

Clinical Trial Recruitment Software: What Sites Actually Need (and What's Just Hype)

A no-nonsense breakdown of the recruitment software landscape — what categories exist, what each solves, and the questions every site should ask before buying.

Patient Recruitment for Clinical Trials: Why 85% of Trials Miss Enrollment Targets

The enrollment crisis is systemic, not accidental. Here's why sites struggle to hit their numbers — and the operational changes that actually move the needle.

AI for Clinical Trial Recruitment: From Screening Calls to Predictive Matching

How AI is changing the front end of the recruitment funnel — automated prescreening, voice agents, and the honest state of what works today versus what's still overhyped.

Clinical Trial Site Management Tools: The Stack Every High-Performing Site Uses

From eConsent to CTMS to participant communication — the software layers that reduce CRC workload and keep enrollment on track.

Clinical Trial Retention Strategies: Reducing Dropout Before It Derails Your Study

Patient dropout is the second-biggest reason trials fail to complete. The root causes of attrition and the operational strategies that actually keep participants enrolled.

IRB Approval Process for Clinical Trials: What Sites Need to Know

What IRB reviewers look for, where submissions get delayed, and how research sites can prepare stronger applications that clear review the first time.

TrialVoice — AI Voice Agent for Your Trial Site

Automate prescreening calls, handle after-hours inquiries, and reduce CRC workload by up to 60%. Purpose-built for clinical research sites. $1,500/site/month.

Learn About TrialVoice →